Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDelgado, Ana-
dc.contributor.authorGriera Farres, Rosa-
dc.contributor.authorLlor Brunés, Núria-
dc.contributor.authorLópez-Aguilar, Ester-
dc.contributor.authorBusquets i Viñas, Ma. Antonia-
dc.contributor.authorNoé Mata, Verónica-
dc.contributor.authorCiudad i Gómez, Carlos Julián-
dc.description.abstractBackground: One of the most significant limitations that therapeutic oligonucleotides present is the development of specific and efficient delivery vectors for the internalization of nucleic acids into cells. Therefore, there is a need for the development of new transfection agents that ensure a proper and efficient delivery into mammalian cells. Methods: We describe the synthesis of 1,3,5-tris[(4-oelyl-1-pyridinio)methyl]benzene tribromide (TROPY) and proceeded to the validation of its binding capacity toward oligonucleotides, the internalization of DNA into the cells, the effect on cell viability, apoptosis, and its capability to transfect plasmid DNA. Results: The synthesis and chemical characterization of TROPY, which can bind DNA and transfect oligonucleotides into mammalian cells through clathrin and caveolin-mediated endocytosis, are described. Using a PPRH against the antiapoptotic survivin gene as a model, we validated that the complex TROPY-PPRH decreased cell viability in human cancer cells, increased apoptosis, and reduced survivin mRNA and protein levels. TROPY was also able to stably transfect plasmid DNA, as demonstrated by the formation of viable colonies upon the transfection of a dhfr minigene into dhfr-negative cells and the subsequent metabolic selection. Conclusions: TROPY is an efficient transfecting agent that allows the delivery of therapeutic oligonucleotides, such as PPRHs and plasmid DNA, inside mammalian cells. Keywords: therapeutic oligonucleotide; PPRH; hairpin; delivery; transfection agent; mammalian cell; cancer; cell viability; apoptosis; stable transfection-
dc.relation.isformatofReproducció del document publicat a:
dc.relation.ispartofPharmaceutics, 2023-
dc.rightscc-by (c) Delgado, Ana et al., 2023-
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationSíntesi orgànica-
dc.subject.otherOrganic synthesis-
dc.titleTrioleyl Pyridinium, a Cationic Transfection Agent for the Lipofection of Therapeutic Oligonucleotides into Mammalian Cells-
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
729899.pdf3.59 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons